A randomized phase 3 study of lenalidomide versus placebo in RBC transfusion-dependent patients with Low-/Intermediate-1-risk myelodysplastic syndromes with del5q.
暂无分享，去创建一个
M. Cazzola | A. Ganser | G. Mufti | B. Quesnel | L. Nilsson | M. Lübbert | P. Fenaux | E. Hellström-Lindberg | A. Giagounidis | D. Bowen | U. Platzbecker | M. Mittelman | B. Schlegelberger | G. Sanz | O. Beyne-Rauzy | C. Aul | P. Muus | R. Knight | D. Selleslag | C. del Cañizo | A. Guerci-Bresler | P. T. te Boekhorst | T. Fu | J. Francis